Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study
Background: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. Methods: Electronic surveys wer...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/2/123 |
id |
doaj-aee7a0fe1c7842ceb457231e4e37cae0 |
---|---|
record_format |
Article |
spelling |
doaj-aee7a0fe1c7842ceb457231e4e37cae02021-02-05T00:01:18ZengMDPI AGVaccines2076-393X2021-02-01912312310.3390/vaccines9020123Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM StudyÁlvaro Sosa Liprandi0Ezequiel José Zaidel1Ricardo Lopez Santi2John Jairo Araujo3Manuel Alfonso Baños González4Juan Martín Busso5Luz Cabral6Jorge Camilletti7Juan Erriest8Roberto Flores9Ezequiel Forte10Mirecly Guzman Ramos11Máxima Mendez Castillo12Leonardo Josué Ramírez Zambrano13Carmen Roa14Piero Custodio–Sanchez15Gustavo Solache Ortiz16Bernardo Spitz17Adrián Baranchuk18Sanatorio Güemes, Buenos Aires C1180AAX, ArgentinaSanatorio Güemes, Buenos Aires C1180AAX, ArgentinaHospital Italiano de La Plata, La Plata B1900, ArgentinaCentro Cardiovascular Somer Incare, Rionegro 054040, ColombiaCardiology Department, Universidad Juarez Autónoma de Tabasco, Villahermosa Tabasco 86040, MexicoSanatorio San José, Buenos Aires c1425, ArgentinaCentro Médico Nacional-Hospital Nacional Itauguá, Itauguá 2740, ParaguayHospital Italiano de La Plata, La Plata B1900, ArgentinaHospital Italiano de La Plata, La Plata B1900, ArgentinaHospital Ramón Carrillo, Santiago del Estero G4200, ArgentinaCENDIC Centro Diagnóstico Cardiovascular, Concordia E3202, ArgentinaIVSS Dr Luis Guada Lacau, Valencia 2300, VenezuelaCEDIMAT, Santo Domingo 10514, Dominican RepublicCentro Clínico San Cristobal, San Cristobal 5001, VenezuelaHospital Metropolitano de Santiago, Santo Domingo 51000, Dominican RepublicHospital Nacional Almanzor Aguinaga Asenjo -Essalud, Chiclayo 14001, PeruInstituto de Cardiología Preventiva, San Juan del Río 76800, MexicoClínica Cuyo, Mendoza M5500, ArgentinaQueen’s University, Kingston, ON K7L 3N6, CanadaBackground: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. Methods: Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020. Results: 4216 patients were analyzed. Mean age 60 (±15) years and 49% females. Global IV rate was 46.5% and PV 24.6%. Vaccinated patients were older (IV = 63 vs. 58 years; PV = 68 vs. 59, <i>p</i> < 0.01) but without gender difference. Vaccination rates were greater in higher-risk groups (65+, diabetics, heart failure), but not in coronary artery disease patients. In the Southern cone, the rate of IV and PV was approximately double that in the tropical regions of the Americas. In a multivariate model, geographic zone (IV = OR 2.02, PV = OR 2.42, <i>p</i> < 0.001), age (IV = OR 1.023, PV = OR 1.035, <i>p</i> < 0.001), and incomes (IV = OR 1.28, PV = OR 1.58, <i>p</i> < 0.001) were predictors for vaccination. Conclusions: During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth.https://www.mdpi.com/2076-393X/9/2/123COVID-19SARS-CoV-2Influenza vaccinationpneumococcal vaccinationcardio–metabolic |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Álvaro Sosa Liprandi Ezequiel José Zaidel Ricardo Lopez Santi John Jairo Araujo Manuel Alfonso Baños González Juan Martín Busso Luz Cabral Jorge Camilletti Juan Erriest Roberto Flores Ezequiel Forte Mirecly Guzman Ramos Máxima Mendez Castillo Leonardo Josué Ramírez Zambrano Carmen Roa Piero Custodio–Sanchez Gustavo Solache Ortiz Bernardo Spitz Adrián Baranchuk |
spellingShingle |
Álvaro Sosa Liprandi Ezequiel José Zaidel Ricardo Lopez Santi John Jairo Araujo Manuel Alfonso Baños González Juan Martín Busso Luz Cabral Jorge Camilletti Juan Erriest Roberto Flores Ezequiel Forte Mirecly Guzman Ramos Máxima Mendez Castillo Leonardo Josué Ramírez Zambrano Carmen Roa Piero Custodio–Sanchez Gustavo Solache Ortiz Bernardo Spitz Adrián Baranchuk Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study Vaccines COVID-19 SARS-CoV-2 Influenza vaccination pneumococcal vaccination cardio–metabolic |
author_facet |
Álvaro Sosa Liprandi Ezequiel José Zaidel Ricardo Lopez Santi John Jairo Araujo Manuel Alfonso Baños González Juan Martín Busso Luz Cabral Jorge Camilletti Juan Erriest Roberto Flores Ezequiel Forte Mirecly Guzman Ramos Máxima Mendez Castillo Leonardo Josué Ramírez Zambrano Carmen Roa Piero Custodio–Sanchez Gustavo Solache Ortiz Bernardo Spitz Adrián Baranchuk |
author_sort |
Álvaro Sosa Liprandi |
title |
Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study |
title_short |
Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study |
title_full |
Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study |
title_fullStr |
Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study |
title_full_unstemmed |
Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study |
title_sort |
influenza and pneumococcal vaccination in non-infected cardiometabolic patients from the americas during the covid-19 pandemic. a sub-analysis of the corcovid-latam study |
publisher |
MDPI AG |
series |
Vaccines |
issn |
2076-393X |
publishDate |
2021-02-01 |
description |
Background: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. Methods: Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020. Results: 4216 patients were analyzed. Mean age 60 (±15) years and 49% females. Global IV rate was 46.5% and PV 24.6%. Vaccinated patients were older (IV = 63 vs. 58 years; PV = 68 vs. 59, <i>p</i> < 0.01) but without gender difference. Vaccination rates were greater in higher-risk groups (65+, diabetics, heart failure), but not in coronary artery disease patients. In the Southern cone, the rate of IV and PV was approximately double that in the tropical regions of the Americas. In a multivariate model, geographic zone (IV = OR 2.02, PV = OR 2.42, <i>p</i> < 0.001), age (IV = OR 1.023, PV = OR 1.035, <i>p</i> < 0.001), and incomes (IV = OR 1.28, PV = OR 1.58, <i>p</i> < 0.001) were predictors for vaccination. Conclusions: During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth. |
topic |
COVID-19 SARS-CoV-2 Influenza vaccination pneumococcal vaccination cardio–metabolic |
url |
https://www.mdpi.com/2076-393X/9/2/123 |
work_keys_str_mv |
AT alvarososaliprandi influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT ezequieljosezaidel influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT ricardolopezsanti influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT johnjairoaraujo influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT manuelalfonsobanosgonzalez influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT juanmartinbusso influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT luzcabral influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT jorgecamilletti influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT juanerriest influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT robertoflores influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT ezequielforte influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT mireclyguzmanramos influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT maximamendezcastillo influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT leonardojosueramirezzambrano influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT carmenroa influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT pierocustodiosanchez influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT gustavosolacheortiz influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT bernardospitz influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy AT adrianbaranchuk influenzaandpneumococcalvaccinationinnoninfectedcardiometabolicpatientsfromtheamericasduringthecovid19pandemicasubanalysisofthecorcovidlatamstudy |
_version_ |
1724284584312438784 |